CTOs on the Move

Finnzymes

www.finnzymes.us

 
Finnzymes, Inc. is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.finnzymes.us
  • 800 W Cummings Park Ste 5550
    Woburn, MA USA 01801
  • Phone: 800.993.1283

Executives

Name Title Contact Details

Similar Companies

DocuSys, Inc.

DocuSys, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Atlanta, GA. To find more information about DocuSys, Inc., please visit www.docusys.net

Lowe Healthcare Worldwide

Lowe Healthcare Worldwide is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Universal-Macomb Ambulance

Universal-Macomb Ambulance is one of the premiere ambulance transport providers in Southeast Michigan. We offer a broad range of ambulance and transport services while serving a number of public safety agencies in our service area. In addition to the

Ideal Image

IDEAL IMAGE is a premier global leader in laser hair removal and non-surgical medical cosmetic services. With over 120 locations, our success is attributed to a shared passion for "Changing people`s lives forever!" We use only licensed medical and nursing professionals to perform our treatments. If you are interested in joining a company that values its employees and encourages job ownership in a supportive environment, please visit our career site at www.idealimage.com to learn more about the company and view a list of open positions.

Stilla Technologies

Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.